Rich Russo

Chief Financial Officer and Interim Chief Executive Officer at BIONIK Laboratories
On the record
Represented by:
Share profile 

Leveraging over 20 years of experience with a public accounting, and primarily public company mix. In my last role at ICarbonX, a privately held digital health management company which specializes in artificial intelligence and health data, I was responsible for, among other things, the merger of three companies, involved in fundraising, and the ultimate dissolution of certain affiliated companies. I have managed a variety of areas in the Controllership roles at Cynosure, Juniper Pharmaceuticals and, Pieris Pharmaceuticals. These areas have ranged from Revenue Recognition and SEC compliance to integrating newly acquired subsidiaries and creating an internal control infrastructure. I am able to execute a quality of service to the rest of our organization from a budget and forecast perspective to overseeing payroll. I have been able to hire bright professionals as well as surround myself around expertise in the medical device and pharmaceutical industry.

Recent Quotes
Sign up to view all
  • The InMotion device will provide TGH’s clinicians with an invaluable technology that will offer each of their patients effective and efficient therapy sessions, allowing them to track upwards of 1,000 movements per session. We are thrilled to be working with Tampa General Hospital as we continue to expand our presence with the Kindred network to reach more patients.

Sign up to view all